In last trading session, Jade Biosciences Inc (NASDAQ:JBIO) saw 0.3 million shares changing hands with its beta currently measuring 0.79. Company’s recent per share price level of $7.34 trading at -$0.06 or -0.74% at ring of the bell on the day assigns it a market valuation of $6.77M. That closing price of JBIO’s stock is at a discount of -1159.67% from its 52-week high price of $92.46 and is indicating a premium of 37.74% from its 52-week low price of $4.57. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.24 million shares which gives us an average trading volume of 116.33K if we extend that period to 3-months.
Jade Biosciences Inc (NASDAQ:JBIO) trade information
Upright in the red during last session for losing -0.74%, in the last five days JBIO remained trading in the red while hitting it’s week-highest on Monday, 05/12/25 when the stock touched $7.34 price level, adding 21.16% to its value on the day. Jade Biosciences Inc’s shares saw a change of -24.20% in year-to-date performance and have moved -15.09% in past 5-day. Jade Biosciences Inc (NASDAQ:JBIO) showed a performance of -25.05% in past 30-days. Number of shares sold short was 0.15 million shares which calculate 0.63 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 19 to the stock, which implies a rise of 61.37% to its current value. Analysts have been projecting 19 as a low price target for the stock while placing it at a high target of 19. It follows that stock’s current price would drop -158.86% in reaching the projected high whereas dropping to the targeted low would mean a loss of -158.86% for stock’s current value.
Jade Biosciences Inc (JBIO) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -77.98% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 84.58% while estimates for its earnings growth in next 5 years are of 69.77%.
Jade Biosciences Inc (NASDAQ:JBIO)’s Major holders
Insiders are in possession of 0.04% of company’s total shares while institution are holding 16.29 percent of that, with stock having share float percentage of 16.29%. Investors also watch the number of corporate investors in a company very closely, which is 16.29% institutions for Jade Biosciences Inc that are currently holding shares of the company.
On the other hand, iShares Trust-iShares Russell 2000 ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 13.11 shares of worth $96314.0 or 0.04% of the total outstanding shares. The later fund manager was in possession of 12.98 shares on Dec 31, 2024 , making its stake of worth around $95338.0 in the company or a holder of 0.04% of company’s stock.
